Bellevue Group AG

Q3 2022 13F Holdings Report, Stock Holdings

Signature - Title
Christoph Eisenring / Michael Hutter - Head Legal & Compliance / CFO
Location
Kuesnacht, Switzerland
Holdings as of
30 Sep 2022
Value $
$6.96B
Num holdings
176
Filing time
14 Nov 2022, 13:52:52 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included IONS, VRTX, ARGX, NBIX, and ALNY.
Previous filing
Q2 2022 - 11 Aug 2022
Next filing
Q4 2022 - 14 Feb 2023
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q3 compared to 2022 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Christoph Eisenring / Michael Hutter Head Legal & Compliance / CFO Kuesnacht, Switzerland 11 Nov 2022

Other Included Managers (3):

Num Name Location File Number
1 BB BIOTECH AG Schaffhausen, Switzerland 028-06964
2 Bellevue Asset Management AG Zurich 028-16892
3 Bellevue Asset Management (UK) Ltd. London, United Kingdom 028-20408